{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06109181",
            "orgStudyIdInfo": {
                "id": "LX2020-01"
            },
            "organization": {
                "fullName": "Lexeo Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "Gene Therapy for ACM Due to a PKP2 Pathogenic Variant",
            "officialTitle": "A Phase 1/2 Study of the Safety and Efficacy of LX2020 Gene Therapy in Patients With Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "gene-therapy-for-acm-due-to-a-pathogenic-variant"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-25",
            "studyFirstSubmitQcDate": "2023-10-25",
            "studyFirstPostDateStruct": {
                "date": "2023-10-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Lexeo Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1/2, first-in-human, open-label, intravenous, dose-escalating, multicenter trial that is designed to assess the safety and tolerability of LX2020 in adult patients with PKP2-ACM"
        },
        "conditionsModule": {
            "conditions": [
                "Arrhythmogenic Cardiomyopathy",
                "PKP2-ACM",
                "PKP2-ARVC"
            ],
            "keywords": [
                "Arrhythmogenic Cardiomyopathy",
                "ACM",
                "Cardiomyopathy",
                "ARVC",
                "Arrhythmogenic Right Ventricular",
                "Arrhythmogenic Right Ventricular Dysplasia",
                "Genetic cardiomyopathy",
                "Gene Therapy",
                "PKP2 Gene",
                "Plakophilin-2",
                "LX2020",
                "HEROIC-PKP2",
                "Ventricular Arrhythmia",
                "PVCs",
                "Sudden Cardiac Death",
                "Cardiac Arrest"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LX2020",
                    "type": "EXPERIMENTAL",
                    "description": "Single ascending dose of LX2020, with a starting dose of 2.0 x10\\^13 gc/kg, in multiple cohorts",
                    "interventionNames": [
                        "Genetic: LX2020"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "LX2020",
                    "description": "LX2020 is an adeno-associated viral vector encoding the human Plakophilin-2 (PKP2) gene (AAVrh.10hPKP2)",
                    "armGroupLabels": [
                        "LX2020"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of subjects who experienced at least 1 treatment emergent adverse event (TEAE) and/or 1 treatment emergent serious adverse event (TESAE).",
                    "description": "Evaluation of Safety and Tolerability of LX2020",
                    "timeFrame": "12 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Selected Exploratory",
                    "description": "Change in the frequency of ventricular arrhythmias from baseline.",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Selected Inclusion Criteria:\n\n* Adults with a clinical diagnosis of ACM meeting the 2010 revised Task Force Criteria (TFC)\n* Genetic testing documenting a pathogenic or likely pathogenic variant in PKP2\n* Frequent premature ventricular complexes (PVCs)\n* Implantable cardioverter-defibrillator (ICD) implantation \u2265 12 weeks prior to consent\n* Left ventricular ejection fraction \u2265 50%\n\nSelected Exclusion Criteria:\n\n* Evidence of variant(s) in addition to PKP2 that meets the standard criteria to be considered pathogenic or likely pathogenic for ACM\n* Other cardiac abnormalities as specified in the protocol\n* New York Heart Association Functional Class III and IV at the time of consent\n* History of prior gene transfer therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "LEXEO Clinical Trials",
                    "role": "CONTACT",
                    "phone": "212-547-9879",
                    "email": "clinicaltrials@lexeotx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "LEXEO Clinical Trials",
                    "affiliation": "Lexeo Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eric Smith, MD",
                            "role": "CONTACT",
                            "phone": "734-764-4500",
                            "email": "ersm@med.umich.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Medical University of South Carolina",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "843-876-5009",
                            "email": "awkar@musc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9411",
                    "name": "Heart Arrest",
                    "relevance": "LOW"
                },
                {
                    "id": "M6845",
                    "name": "Death",
                    "relevance": "LOW"
                },
                {
                    "id": "M19118",
                    "name": "Death, Sudden, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M21507",
                    "name": "Arrhythmogenic Right Ventricular Dysplasia",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T483",
                    "name": "Arrhythmogenic Right Ventricular Cardiomyopathy",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}